GI Dynamics (ASX:GID) has announced data showing that obese patients treated with its EndoBarrier device showed reduced 10-year cardiovascular risk. [ + ]

Multiple Sclerosis Research Australia has joined a global alliance to work towards better understanding and treating progressive multiple sclerosis. [ + ]

A German hospital has found Nanosonics' (ASX:NAN) trophon EPR ultrasound probe disinfection device to be superior to the standard manual wipe method. [ + ]

Applications are open for the veski Innovation Fellowships that encourage international researchers to relocate to Victoria. [ + ]

The Export Council of Australia (ECA) and the Manufacturing Excellence Taskforce Australia (META) have established a Deregulation Hub, with the purpose of producing an Agenda for Action to inform government on the streamlining of regulation that inhibits the ability of Australian manufacturers to compete internationally. [ + ]

Researchers from Macquarie University have shown that circular dichroism - the differential absorption of a system to left and right circularly polarised light - can be induced in mirror symmetric samples such as circular holes or spheres, so long as structured light is used. [ + ]

The WHO will fund research into using Vaxxas's Nanopatch vaccine delivery technology to help finally eradicate polio worldwide. [ + ]

An external review of the Cooperative Research Centres Program will be led by business leader David Miles.

Orthocell (ASX:OTI) has been granted an Australian patent for its regenerative product Ortho-ATI, while Antisense Therapeutics (ASX:ANP) will soon obtain a European patent for ATL1102. [ + ]

Thousands of engineers from all disciplines are coming to Melbourne for Convention 2014 - claimed to be the largest engineering event ever held in the Southern Hemisphere. [ + ]

In a major coup for the biotechnology industry in Australia, the prestigious International Biotechnology Symposium (IBS) will be held in Melbourne in 2016 in conjunction with the AusBiotech 2016 national conference and Australia Biotech Invest 2016 - making it the largest biotech industry event in Australia's history. [ + ]

Two former CSL (ASX:CSL) scientists have joined Nexvet's veterinary biologics research centre in Melbourne.

GSK is calling for Australian and New Zealand researchers and start-up companies to submit ideas for potential partnership opportunities.

A potential new treatment option for bone marrow transplant patients who develop transplant-related chronic graft-versus-host disease will soon be tested in a clinical trial.

The 2014-15 Laboratory Guide to Workplace Safety has been released. [ + ]